EUVIMEDEUVIMED entdecken
Crossref

The role of biobanks in advancing the national biotechnology strategy in Saudi Arabia

Hisham A Badreldin, Lubna A Alnasser, Tariq Alqahtani, Abdulrahman Aljouie, Nadin Almosnid, Dalal Aldeghaither, Alaa Alshareeda, Sausan Alfaris, Alaa Zare, Zisis Kozlakidis

Eastern Mediterranean Health Journal · 08.12.2025 · 31 (11) · 649-656

DOI: 10.26719/2025.31.11.649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eastern Mediterranean Health Journal, online erschienen am 08.12.2025. Verfasst von Hisham A Badreldin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Saudi Biobank, King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Biotechnology, Biological Specimen Banks. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Saudi Arabia launched its national biotechnology strategy to position the country as a global biotechnology hub by 2040 and enhance biomanufacturing, medical innovation and self-sufficiency in vaccines and genomics.

Aim

To assess the role of biobanks in advancing the national biotechnology strategy, using the Saudi Biobank as a case study.

Methods

We collected operational data from the Saudi Biobank and reviewed literature on biobanks published between 2010 and 2024, guided by the 4 pillars of the Saudi national biobank strategy (vaccine localisation, biopharmaceutical manufacturing, genomics, agricultural biotechnology) and the 5 enabling factors (talent development, infrastructure, regional presence, regulatory excellence, strategic funding). We compared the Saudi data with the global biobanking market data, to illustrate the contributions of biobanks to other aspects of healthcare.

Results

By mid-2024, the Saudi Biobank had enrolled 53 338 participants and collected 589 461 biospecimens. It currently serves as a platform for genomic research, precision medicine, clinical trials, and advanced biotechnology, while also facilitating technology transfer and commercialisation.

Conclusion

The Saudi Biobank is considered one of the most advanced health initiatives in the Eastern Mediterranean Region. To enhance its impact, there is a need to strengthen its capacity through increased and sustained investments, improved data interoperability and data integration, standardised governance systems, increased national and international partnerships and collaborations, and other policy reforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiotechnologyBiological Specimen BanksSaudi ArabiaHumans

Stichwörter der Autor:innen

Saudi Arabiabiobankbiotechnologygenomic researchnational biotechnology strategyvision 2030

Autor:innen und Institutionen

  • Saudi Biobank, King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Population Health Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Data Management Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • College of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • International Agency for Research on Cancer, World Health Organization, Lyon, France.

Förderung

  • World Health Organization

Zitieren

APA

Badreldin, H. A., Alnasser, L. A., Alqahtani, T., Aljouie, A., Almosnid, N., Aldeghaither, D., Alshareeda, A., Alfaris, S., Zare, A., & Kozlakidis, Z. (2025). The role of biobanks in advancing the national biotechnology strategy in Saudi Arabia. Eastern Mediterranean Health Journal, 31(11), 649-656. https://doi.org/10.26719/2025.31.11.649

Vancouver

Badreldin HA, Alnasser LA, Alqahtani T, Aljouie A, Almosnid N, Aldeghaither D, et al. The role of biobanks in advancing the national biotechnology strategy in Saudi Arabia. Eastern Mediterranean Health Journal. 2025;31(11):649-656. doi:10.26719/2025.31.11.649

BibTeX
@article{Badreldin2025,
  author = {Badreldin, Hisham A and Alnasser, Lubna A and Alqahtani, Tariq and Aljouie, Abdulrahman and Almosnid, Nadin and Aldeghaither, Dalal and Alshareeda, Alaa and Alfaris, Sausan and Zare, Alaa and Kozlakidis, Zisis},
  title = {The role of biobanks in advancing the national biotechnology strategy in Saudi Arabia},
  journal = {Eastern Mediterranean Health Journal},
  year = {2025},
  volume = {31},
  number = {11},
  pages = {649--656},
  doi = {10.26719/2025.31.11.649}
}
Kostenlos starten →